Rein Therapeutics Inc (RNTX) Stock Price, Quote, News & History

RNTXNASDAQ
$0.8649
-0.0801-8.48%
At close: Jun 17, 5:00 PM EST
$0.8810
0.01611.86%
After Hours: 5:59 PM EST
Loading...

Key Statistics

Open
$0.95
Close
$0.86
Volume / Avg.
749.66K / 650.60K
Day Range
$0.86 - $0.99
52 Wk Range
0.89 - 2.18
Market Cap
$75.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
32
Short Interest
0.48%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-16.61M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
13.67M
Free Cash Flow (TTM)
-16.61M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.94M

Analyst Trends and Forecast

0
0
0
0
Jan
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$81.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-201.06%
Earnings Yield % (FWD)
-73.02%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.39

Company Debt

Total Debt
$4.92M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.45M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.95
Close
$0.86
Volume / Avg.
749.66K / 650.60K
Day Range
$0.86 - $0.99
52 Wk Range
0.89 - 2.18
Market Cap
$75.36M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
32
Short Interest
0.48%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Rein Therapeutics (RNTX) stock?

A

You can purchase shares of Rein Therapeutics (NASDAQ:RNTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Rein Therapeutics (RNTX) competitors?

A

There are no as such competitors for Rein Therapeutics.

Q

What is the forecast, or price target, for Rein Therapeutics (RNTX) stock?

A

Rein Therapeutics has a consensus price target of $8.00.

Q

What is the current price for Rein Therapeutics (RNTX)?

A

The stock price for Rein Therapeutics (NASDAQ: RNTX) is $0.881 last updated June 17, 2026 at 5:59 PM EDT.

Q

Does Rein Therapeutics (RNTX) pay a dividend?

A

There are no upcoming dividends for Rein Therapeutics.

Q

When is Rein Therapeutics (NASDAQ:RNTX) reporting earnings?

A

Rein Therapeutics does not have any upcoming earnings scheduled.

Q

Is Rein Therapeutics (RNTX) going to split?

A

There is no upcoming split for Rein Therapeutics.

Q

What sector and industry does Rein Therapeutics (RNTX) operate in?

A

Rein Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.